The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease.
 
Andrea Pretta
Consulting or Advisory Role - Merck; Sanofi
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Takeda; Teysuno
Speakers' Bureau - AstraZeneca; Bayer; BMS; Lilly; MSD Oncology
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis
 
Federica Marmorino
No Relationships to Disclose
 
Federica Bertuzzi
No Relationships to Disclose
 
Pina Ziranu
Consulting or Advisory Role - SERVIER
 
Krisida Cerma
No Relationships to Disclose
 
Paolo Ciracì
No Relationships to Disclose
 
Federica Manoni
Travel, Accommodations, Expenses - GlaxoSmithKline; LEO Pharma
 
Clelia Donisi
No Relationships to Disclose
 
Maria Caterina De Grandis
No Relationships to Disclose
 
Ada Taravella
No Relationships to Disclose
 
Silvia Marchesi
No Relationships to Disclose
 
Valeria Pusceddu
Consulting or Advisory Role - Amgen
 
Giulia Maddalena
No Relationships to Disclose
 
Roberta Fazio
No Relationships to Disclose
 
Riccardo Giampieri
No Relationships to Disclose
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi-Sankyo; Ipsen; Johnson&Johnson; Merck Serono; MSD Oncology; Pierre Fabre; Rottapharm Biotech; Seagen; SERVIER; Takeda
Consulting or Advisory Role - Agenus; Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; BMS; Daiichi-Sankyo; Gilead Sciences; GlaxoSmithKline; Incyte; Jazz Pharmaceuticals,; Johnson & Johnson/Janssen; Merck Serono; MSD Oncology; Pfizer; Pierre Fabre; Rottapharm Biotech; SERVIER; Takeda
Research Funding - Agenus (Inst); Amgen (Inst); Astrazeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lilly (Inst); Rottapharm Biotech (Inst)
Travel, Accommodations, Expenses - Merck Serono; Pierre Fabre; Takeda Science Foundation
 
Chiara Cremolini
Honoraria - Amgen; Bayer; GlaxoSmithKline; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER; Takeda
Consulting or Advisory Role - Amgen; Bayer; Bicara Therapeutics; MSD; Nordic Bioscience; Pierre Fabre; Revolution Medicines; Roche; Rottapharm Biotech; Takeda
Speakers' Bureau - Merck; MSD; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Beigene; Bristol-Myers Squibb; Daiichi Sankyo; Fosun Pharma; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD; Nimbus Therapeutics; Rottapharm Biotech; SERVIER; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Mario Scartozzi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; Rottapharm Biotech; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; SERVIER
Research Funding - Sanofi
Travel, Accommodations, Expenses - Merck; MSD; SERVIER